{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:40Z","timestamp":1794047500389,"version":"4.8.0"},"reference-count":51,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Acute leukemias represent the first cause of cancer in children. Their prognosis has improved significantly due to remarkable advances in therapeutic management, despite the risk of long-term consequences, especially for patients who underwent allogenic hematopoietic stem cell transplantation (aHSCT). Through the Leukemia in Children and Adolescents (LEA) long-term follow-up cohort (clinicaltrials gov. Identifier: NCT01756599), we conducted a French national multicenter prospective study on the occurrence and risk factors of chronic kidney disease (CKD), differentiating glomerular and tubular dysfunctions, corresponding to the NephroLEA project. Among the 1,676 patients included, the median age at evaluation was 15.8 (interquartile range [IQR], 11.3-20.5) years, with a median follow-up of 9.2 (IQR, 5.8-13.9) years. aHSCT was performed on 343 (20.6%) patients, half of whom have undergone the procedure after achieving second or greater remission. A higher percentage of children among transplanted patients had diastolic and systolic blood pressure above the 95th, with 13.7% versus 5.2% (P=3x10-3) and 15% versus 6.5% (P=9x10-2), respectively. A total of 187 patients (11.1%) had a mild CKD (i.e., eGFR between 75 and 90 mL\/min\/1.73 m2), while 3% (N=50) exhibited mild to severe CKD (eGFR &lt;75 mL\/min\/1.73 m2). Notably, no patient reached kidney failure. Twenty-one patients (1.3%) had decreased glomerular filtration rate associated with tubular impairment. The principal risk factors for developing CKD were aHSCT and leukemia relapse. In conclusion, CKD represents a long-term risk for patients who relapsed and\/or underwent aHSCT. These patients could benefit from nephroprotection advice to further improve their long-term outcomes, which is becoming a public health issue.<\/jats:p>","DOI":"10.3324\/haematol.2024.286940","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T03:56:16Z","timestamp":1743652576000},"page":"1987-1997","source":"Crossref","is-referenced-by-count":2,"title":["Long-term kidney complications in childhood leukemia survivors: a study from the Childhood and Adolescent Leukemia (LEA) project"],"prefix":"10.3324","volume":"110","author":[{"given":"Carine","family":"Domenech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saultier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Dominique","family":"Tabone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Pasquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyne","family":"Poir\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Plantaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Hugues","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chastagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Thouvenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Kanold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Pellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Reguerres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Auquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Derain-Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"78431","doi-asserted-by":"crossref","unstructured":"Clavel J, Goubin A, Auclerc MF. Incidence of childhood leukaemia and non-Hodgkin\u2019s lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. Eur J Cancer Prev. 2004; 13(2):97-103.","DOI":"10.1097\/00008469-200404000-00002"},{"key":"78432","doi-asserted-by":"crossref","unstructured":"Domenech C, Suciu S, De Moerloose B. Dexamethasone (6 mg\/m2\/day) and prednisolone (60 mg\/m2\/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial. Haematologica. 2014; 99(7):1220-1227.","DOI":"10.3324\/haematol.2014.103507"},{"key":"78433","doi-asserted-by":"crossref","unstructured":"Creutzig U, Zimmermann M, Bourquin J-P. Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood. 2013; 122(1):37-43.","DOI":"10.1182\/blood-2013-02-484097"},{"key":"78434","doi-asserted-by":"crossref","unstructured":"Leung W, Campana D, Yang J. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood. 2011; 118(2):223-230.","DOI":"10.1182\/blood-2011-01-333070"},{"key":"78435","doi-asserted-by":"crossref","unstructured":"Pession A, Masetti R, Rizzari C. Results of the AIEOP AML 2002\/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. Blood. 2013; 122(2):170-178.","DOI":"10.1182\/blood-2013-03-491621"},{"key":"78436","doi-asserted-by":"crossref","unstructured":"da Silva Selistre L, Renard C, Bacchetta J. Teenagers and young adults with a past of allogenic hematopoietic stem cell transplantation are at significant risk of chronic kidney disease. Pediatr Nephrol. 2022; 37(6):1365-1375.","DOI":"10.1007\/s00467-021-05319-x"},{"key":"78437","doi-asserted-by":"crossref","unstructured":"Malyszko J, Kozlowska K, Kozlowski L, Malyszko J. Nephrotoxicity of anticancer treatment. Nephrol Dial Transplant. 2017; 32(6):924-936.","DOI":"10.1093\/ndt\/gfw338"},{"key":"78438","doi-asserted-by":"crossref","unstructured":"Tsurusawa M, Gosho M, Mori T. Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma. Pediatr Blood Cancer. 2015; 62(2):279-284.","DOI":"10.1002\/pbc.25305"},{"key":"78439","doi-asserted-by":"crossref","unstructured":"Kwatra NS, Meany HJ, Ghelani SJ, Zahavi D, Pandya N, Majd M. Glomerular hyperfiltration in children with cancer: prevalence and a hypothesis. Pediatr Radiol. 2017; 47(2):221-226.","DOI":"10.1007\/s00247-016-3733-5"},{"key":"78440","doi-asserted-by":"crossref","unstructured":"Perazella MA. Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol. 2012; 7(10):1713-1721.","DOI":"10.2215\/CJN.02780312"},{"key":"78441","doi-asserted-by":"crossref","unstructured":"Ruggiero A, Ferrara P, Attin\u00e0 G, Rizzo D, Riccardi R. Renal toxicity and chemotherapy in children with cancer. Br J Clin Pharmacol. 2017; 83(12):2605-2614.","DOI":"10.1111\/bcp.13388"},{"key":"78442","doi-asserted-by":"crossref","unstructured":"Skinner R. Nephrotoxicity of cancer treatment in children. Pediatric Health. 2010; 4(5):519-538.","DOI":"10.2217\/phe.10.60"},{"key":"78443","doi-asserted-by":"crossref","unstructured":"Krishnappa V, Gupta M, Manu G, Kwatra S, Owusu O-T, Raina R. Acute kidney injury in hematopoietic stem cell transplantation: a review. Int J Nephrol. 2016; 2016:5163789.","DOI":"10.1155\/2016\/5163789"},{"key":"78444","doi-asserted-by":"crossref","unstructured":"Kizilbash SJ, Kashtan CE, Chavers BM, Cao Q, Smith AR. Acute kidney injury and the risk of mortality in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016; 22(7):1264-1270.","DOI":"10.1016\/j.bbmt.2016.03.014"},{"key":"78445","doi-asserted-by":"crossref","unstructured":"Isoda T, Ito S, Kajiwara M, Nagasawa M. Successful high-dose methotrexate chemotherapy in a patient with acute lymphocytic leukemia who developed acute renal failure during the initial treatment. Pediatr Int. 2007; 49(6):1018-1019.","DOI":"10.1111\/j.1442-200X.2007.02461.x"},{"key":"78446","doi-asserted-by":"crossref","unstructured":"Kooijmans ECM, van der Pal HJH, Pluijm SMF. The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors. Kidney Int. 2022; 102(5):1136-1146.","DOI":"10.1016\/j.kint.2022.05.029"},{"key":"78447","doi-asserted-by":"crossref","unstructured":"Pelletier K, C\u00f4t\u00e9 G, Madsen K. Chronic kidney disease, survival and graft-versus-host-disease-free\/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant. Clin Kidney J. 2022; 15(8):1583-1592.","DOI":"10.1093\/ckj\/sfac091"},{"key":"78448","doi-asserted-by":"crossref","unstructured":"Dieffenbach BV, Liu Q, Murphy AJ. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2021; 155:216-226.","DOI":"10.1016\/j.ejca.2021.06.050"},{"key":"78449","doi-asserted-by":"crossref","unstructured":"Stotter BR, Chan C, Chanchlani R. Late kidney effects of childhood cancer and cancer therapies. Adv Chronic Kidney Dis. 2021; 28(5):490-501.","DOI":"10.1053\/j.ackd.2021.09.001"},{"key":"78450","doi-asserted-by":"crossref","unstructured":"Warady BA, Abraham AG, Schwartz GJ. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the Chronic Kidney Disease in Children (CKiD) cohort. Am J Kidney Dis. 2015; 65(6):878-888.","DOI":"10.1053\/j.ajkd.2015.01.008"},{"key":"78451","doi-asserted-by":"crossref","unstructured":"Kumar R, Reed S, Stanek JR, Mahan JD. Defining kidney outcomes in children with acute lymphoblastic leukemia in the modern era. Pediatr Nephrol. 2022; 37(9):2119-2126.","DOI":"10.1007\/s00467-021-05402-3"},{"key":"78452","doi-asserted-by":"crossref","unstructured":"Shroff R. Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation. Pediatr Nephrol. 2021; 36(8):2537-2544.","DOI":"10.1007\/s00467-021-05102-y"},{"key":"78453","doi-asserted-by":"crossref","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32(5 Suppl 3):S112-119.","DOI":"10.1053\/ajkd.1998.v32.pm9820470"},{"key":"78454","doi-asserted-by":"crossref","unstructured":"Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol. 2012; 23(4):578-585.","DOI":"10.1681\/ASN.2011111115"},{"key":"78455","doi-asserted-by":"crossref","unstructured":"Saultier P, Auquier P, Bertrand Y. Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study. Haematologica. 2016; 101(12):1603-1610.","DOI":"10.3324\/haematol.2016.148908"},{"key":"78456","doi-asserted-by":"crossref","unstructured":"Oudin C, Berbis J, Bertrand Y. Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors\u2019 cohort: a comparison with controls from the French population. Haematologica. 2018; 103(4):645-654.","DOI":"10.3324\/haematol.2017.176123"},{"key":"78457","doi-asserted-by":"crossref","unstructured":"Kidney Disease: improving global outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024; 105(Suppl 4):S117-S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"78458","doi-asserted-by":"crossref","unstructured":"Berbis J, Michel G, Baruchel A. Cohort Profile: the French Childhood Cancer Survivor study for leukaemia (LEA cohort). Int J Epidemiol. 2015; 44(1):49-57.","DOI":"10.1093\/ije\/dyu031"},{"key":"78459","doi-asserted-by":"crossref","unstructured":"Bouhanick B, Sosner P, Brochard K. Hypertension in children and adolescents: a position statement from a panel of multidisciplinary experts coordinated by the French Society of Hypertension. Front. Pediatr. 2021; 9:680803.","DOI":"10.3389\/fped.2021.680803"},{"key":"78460","doi-asserted-by":"crossref","unstructured":"Matos V, Van Melle G, Boulat O, Markert M, Bachman C, Guignard JP. Urinary phosphate\/creatinine, calcium\/creatinine, and magnesium\/creatinine ratios in a healthy pediatric population. J Pediatr. 1997; 131(2):252-257.","DOI":"10.1016\/S0022-3476(97)70162-8"},{"key":"78461","doi-asserted-by":"crossref","unstructured":"Pierce CB, Mu\u00f1oz A, Ng DK, Warady BA Furth SL, Schwartz GJ. Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int. 2021; 99(4):948-956.","DOI":"10.1016\/j.kint.2020.10.047"},{"key":"78462","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-612.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"78463","doi-asserted-by":"crossref","unstructured":"Ng DKS, Schwartz GJ, Jacobson LP. Universal GFR determination based on two time points during plasma iohexol disappearance. Kidney Int. 2011; 80(4):423-430.","DOI":"10.1038\/ki.2011.155"},{"key":"78464","doi-asserted-by":"crossref","unstructured":"Stevens PE, Levin A, Kidney disease: improving global outcomes chronic Kidney Disease Guideline Development Work group members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 Clinical Practice Guideline. Ann Intern Med. 2013; 158(11):825-830.","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"key":"78465","doi-asserted-by":"crossref","unstructured":"Delanaye P, Jager KJ, B\u00f6kenkamp A. CKD: a call for an age-adapted definition. J Am Soc Nephrol. 2019; 30(10):1785-1805.","DOI":"10.1681\/ASN.2019030238"},{"key":"78466","doi-asserted-by":"crossref","unstructured":"Adeli K, Higgins V, Trajcevski K, White-Al Habeeb N. The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper. Crit Rev Clin Lab Sci. 2017; 54(6):358-413.","DOI":"10.1080\/10408363.2017.1379945"},{"key":"78467","doi-asserted-by":"crossref","unstructured":"Derain Dubourg L, Aurelle M, Chardon L, Flammier S, Lemoine S, Bacchetta J. Tubular phosphate handling: references from child to adulthood in the era of standardized serum creatinine. Nephrol Dial Transplant. 2022; 37(11):2150-2156.","DOI":"10.1093\/ndt\/gfab331"},{"key":"78468","doi-asserted-by":"crossref","unstructured":"Kooijmans EC, B\u00f6kenkamp A, Tjahjadi NS. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database Syst Rev. 2019; 3(3):CD008944.","DOI":"10.1002\/14651858.CD008944.pub3"},{"key":"78469","doi-asserted-by":"crossref","unstructured":"von Stackelberg A, Locatelli F, Zugmaier G. Phase I\/phase II study of blinatumomab in pediatric patients with relapsed\/ refractory acute lymphoblastic leukemia. J Clin Oncol. 2016; 34(36):4381-4389.","DOI":"10.1200\/JCO.2016.67.3301"},{"key":"78470","doi-asserted-by":"crossref","unstructured":"Maude SL, Laetsch TW, Buechner J. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018; 378(5):439-448.","DOI":"10.1056\/NEJMoa1709866"},{"key":"78471","doi-asserted-by":"crossref","unstructured":"Peters C, Dalle J-H, Locatelli F. Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study. JCO. 2021; 39(4):295-307.","DOI":"10.1200\/JCO.20.02529"},{"key":"78472","doi-asserted-by":"crossref","unstructured":"Willasch AM, Peters C, Sedl\u00e1\u010dek P. Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy? A multicenter EBMT-PDWP study. Bone Marrow Transplant. 2020; 55(8):1540-1551.","DOI":"10.1038\/s41409-020-0854-0"},{"key":"78473","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ana JL, Valc\u00e1rcel D, Martino R. Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience. Biol Blood Marrow Transplant. 2009; 15(1):21-29.","DOI":"10.1016\/j.bbmt.2008.10.011"},{"key":"78474","doi-asserted-by":"crossref","unstructured":"Abboud I, Porcher R, Robin M. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009; 15(10):1251-1257.","DOI":"10.1016\/j.bbmt.2009.05.016"},{"key":"78475","doi-asserted-by":"crossref","unstructured":"Watanabe Nemoto M, Isobe K, Togasaki G. Delayed renal dysfunction after total body irradiation in pediatric malignancies. J Radiat Res. 2014; 55(5):996-1001.","DOI":"10.1093\/jrr\/rru041"},{"key":"78476","doi-asserted-by":"crossref","unstructured":"Frisk P, Arvidson J, Neveus T. Glomerular and tubular function in young adults treated with stem-cell transplantation in childhood. Pediatr Nephrol. 2010; 25(7):1337-1342.","DOI":"10.1007\/s00467-010-1501-6"},{"key":"78477","doi-asserted-by":"crossref","unstructured":"Saultier P, Oudin C, Michel G. Metabolic syndrome among leukemia survivors: still delineating the risk. Metab Syndr Relat Disord. 2017; 15(6):263-265.","DOI":"10.1089\/met.2017.0046"},{"key":"78478","doi-asserted-by":"crossref","unstructured":"Lopez R, Plat G, Bertrand Y. Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study. Bone Marrow Transplant. 2021; 56(6):1422-1425.","DOI":"10.1038\/s41409-020-01180-y"},{"key":"78479","doi-asserted-by":"crossref","unstructured":"Florido R, Daya NR, Ndumele CE. Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) study. J Am Coll Cardiol. 2022; 80(1):22-32.","DOI":"10.1016\/j.jacc.2022.04.042"},{"key":"78480","doi-asserted-by":"crossref","unstructured":"Hsiao W, Lapite A, Faig W. Long-term kidney and cardiovascular complications in pediatric cancer survivors. J Pediatr. 2023; 255:89-97.","DOI":"10.1016\/j.jpeds.2022.10.029"},{"key":"78481","doi-asserted-by":"crossref","unstructured":"Calderon-Margalit R, Golan E, Twig G. History of childhood kidney disease and risk of adult end-stage renal disease. N Engl J Med. 2018; 378(5):428-438.","DOI":"10.1056\/NEJMoa1700993"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/12007\/78269","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12007\/78729","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12007\/78269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:08:31Z","timestamp":1794046111000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/12007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.286940","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}